🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.50
-0.90 (-3.17%)
Nov 20, 2026, 1:30 PM CST

TPEX:4111 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4341,3761,1651,0611,1431,022
Revenue Growth
5.33%18.11%9.86%-7.19%11.81%4.38%
Cost of Revenue
873.39832.82768.25717.76720.57665.72
Gross Profit
560.18543.66397.18343.1422.51356.58
Selling, General & Admin
338.85327.84280.24260.22248.99218.59
Research & Development
16.9116.511821.6719.6918.94
Operating Expenses
355.75344.36298.25281.89268.67237.52
Operating Income
204.43199.398.9361.21153.84119.06
Interest Expense
-0.42-0.52-1.74-1.46-1.53-1.09
Interest & Investment Income
8.78.4214.5816.6430.6
Currency Exchange Gain (Loss)
--17.08-0.434.72-1.76
Other Non Operating Income (Expenses)
26.49-0.411.2211.57.218.06
EBT Excluding Unusual Items
239.19206.8140.0887.46167.24124.86
Gain (Loss) on Sale of Investments
-----5.03-
Gain (Loss) on Sale of Assets
---2.38-0.130.070.12
Asset Writedown
-----6.8
Other Unusual Items
---0--
Pretax Income
239.19206.8137.787.33162.28131.78
Income Tax Expense
52.9842.5227.0718.66-1724.08
Earnings From Continuing Operations
186.21164.28110.6368.67179.28107.7
Earnings From Discontinued Operations
-----25.28-26.95
Net Income
186.21164.28110.6368.67154.0180.75
Net Income to Common
186.21164.28110.6368.67154.0180.75
Net Income Growth
12.61%48.49%61.10%-55.41%90.72%36.54%
Shares Outstanding (Basic)
606060606060
Shares Outstanding (Diluted)
616060606060
Shares Change
0.56%0.40%0.12%-0.16%0.06%0.10%
EPS (Basic)
3.122.751.851.152.571.35
EPS (Diluted)
3.072.721.841.142.561.34
EPS Growth
11.76%47.98%60.83%-55.37%90.77%36.85%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
120.51180.75129.01-26.98109.53-125.53
Free Cash Flow Per Share
1.992.992.15-0.451.82-2.09
Dividend Per Share
1.3001.3000.9520.9521.1430.952
Dividend Growth
36.50%36.50%0%-16.67%20.00%0%
Gross Margin
39.08%39.50%34.08%32.34%36.96%34.88%
Operating Margin
14.26%14.48%8.49%5.77%13.46%11.65%
Profit Margin
12.99%11.94%9.49%6.47%13.47%7.90%
Free Cash Flow Margin
8.41%13.13%11.07%-2.54%9.58%-12.28%
EBITDA
272.69273.56165.23123.17219.2190.95
EBITDA Margin
19.02%19.87%14.18%11.61%19.18%18.68%
D&A For EBITDA
68.2674.2566.361.9665.3671.9
EBIT
204.43199.398.9361.21153.84119.06
EBIT Margin
14.26%14.48%8.49%5.77%13.46%11.65%
Effective Tax Rate
22.15%20.56%19.66%21.36%-18.27%
Revenue as Reported
1,4341,376----